![]() Veterinary CRO And CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal (Companion Animals, Livestock Animals), By Service (Discovery, Development, Manufacturing, Packaging & Labeling, Market Approval & Post Marketing), By Application (Pharmaceuticals, Biologics, Medical Devices, Others), By Region and Competition, 2020-2030F
Market Overview The Global Veterinary CRO and CDMO Market, valued at USD 5.78 Billion in 2024, is projected to reach USD 9.65 Billion by 2030, growing at a CAGR of 8.90%. This growth is fueled by ... もっと見る
SummaryMarket OverviewThe Global Veterinary CRO and CDMO Market, valued at USD 5.78 Billion in 2024, is projected to reach USD 9.65 Billion by 2030, growing at a CAGR of 8.90%. This growth is fueled by the increasing tendency of pharmaceutical and biotechnology firms to outsource research, development, and manufacturing to reduce operational loads and accelerate timelines. Rising demand for veterinary therapeutics, vaccines, and biologics—particularly for companion animals and livestock—has amplified the need for cost-efficient and compliant contract organizations. CROs support clinical and regulatory functions, while CDMOs offer full-spectrum services from formulation to commercial manufacturing. Additionally, the surge in zoonotic diseases and infectious threats has intensified R&D investments in animal health, boosting the market for specialized outsourcing partners. A major trend influencing the market is the uptick in strategic collaborations and acquisitions among CROs, CDMOs, and veterinary drug developers, driven by the need to broaden global presence and integrate tech-enabled platforms like digital tools and biomarker studies in clinical research. Key Market Drivers Increase in Companion Animal Ownership and Healthcare Spending The growing number of companion animals and rising expenditure on their healthcare are pivotal factors driving the Veterinary CRO and CDMO market. Increasingly, pets are being viewed as family members, reshaping consumer spending patterns. According to the 2024 Pet Ownership Survey by the American Veterinary Medical Association, 45.5% of U.S. households own dogs and 32.1% own cats—amounting to nearly 90 million dogs and 74 million cats. Annual veterinary spending averages USD 580 per dog and USD 433 per cat. This surge in pet population and associated healthcare costs has led pharmaceutical and biotech companies to expand their veterinary pipelines, thereby increasing the demand for outsourced R&D and manufacturing services. Key Market Challenges Limited Availability of Skilled Veterinary Research Professionals A significant hurdle in the Global Veterinary CRO and CDMO Market is the shortage of skilled veterinary research professionals. Veterinary clinical and preclinical studies require specialized knowledge across diverse species, drug mechanisms, behavioral patterns, and compliance standards. Unlike human trials, veterinary research spans a wide array of animals—companion pets, livestock, equines, and exotic species—each with unique biological needs. This diversity demands expertise in veterinary science, clinical trial methodologies, ethical considerations, and animal care protocols. However, a global shortfall of such multidisciplinary professionals hampers the scalability, timeline adherence, and quality maintenance capabilities of CROs and CDMOs. Key Market Trends Increased Demand for Biologics and Advanced Veterinary Therapeutics The demand for biologics and next-generation veterinary therapeutics is significantly shaping the Veterinary CRO and CDMO market. As animal health issues become more complex, there’s a growing preference for high-efficacy biologics like monoclonal antibodies, recombinant proteins, and DNA-based vaccines over traditional small-molecule drugs. These innovative solutions are being developed to address serious conditions such as cancer, autoimmune diseases, and chronic infections in both companion and farm animals. This trend is expanding the need for specialized services from CROs and CDMOs, including immunogenicity evaluations, bioanalytical testing, and biologics manufacturing under high-containment protocols. The advanced infrastructure and analytical capabilities required for biologics are fueling the reliance on expert contract organizations. Key Market Players • Fortrea Holdings Inc. • Charles River Laboratories International, Inc. • Clinvet (Pty) Ltd. • KLIFOVET GmbH • Veterinary Research Management, Inc. • VETSPIN SRL • Inotiv, Inc. • IDEXX Laboratories, Inc. • Vetio Animal Health • TriRx Pharmaceutical Services, LLC Report Scope: In this report, the Global Veterinary CRO And CDMO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: • Veterinary CRO And CDMO Market, By Animal: o Companion Animals o Livestock Animals • Veterinary CRO And CDMO Market, By Service: o Discovery o Development o Manufacturing o Packaging & Labeling o Market Approval & Post Marketing • Veterinary CRO And CDMO Market, By Application: o Pharmaceuticals o Biologics o Medical Devices o Others • Veterinary CRO And CDMO Market, By Region: o North America § United States § Canada § Mexico o Europe § France § United Kingdom § Italy § Germany § Spain o Asia-Pacific § China § India § Japan § Australia § South Korea o South America § Brazil § Argentina § Colombia o Middle East & Africa § South Africa § Saudi Arabia § UAE Competitive Landscape Company Profiles: Detailed analysis of the major companies present in the Global Veterinary CRO And CDMO Market. Available Customizations: Global Veterinary CRO And CDMO Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: Company Information • Detailed analysis and profiling of additional market players (up to five). Table of Contents1. Product Overview1.1. Market Definition 1.2. Scope of the Market 1.2.1. Markets Covered 1.2.2. Years Considered for Study 1.2.3. Key Market Segmentations 2. Research Methodology 2.1. Objective of the Study 2.2. Baseline Methodology 2.3. Key Industry Partners 2.4. Major Association and Secondary Sources 2.5. Forecasting Methodology 2.6. Data Triangulation & Validation 2.7. Assumptions and Limitations 3. Executive Summary 3.1. Overview of the Market 3.2. Overview of Key Market Segmentations 3.3. Overview of Key Market Players 3.4. Overview of Key Regions/Countries 3.5. Overview of Market Drivers, Challenges, and Trends 4. Voice of Customer 5. Global Veterinary CRO And CDMO Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Animal (Companion Animals, Livestock Animals) 5.2.2. By Service (Discovery, Development, Manufacturing, Packaging & Labeling, Market Approval & Post Marketing) 5.2.3. By Application (Pharmaceuticals, Biologics, Medical Devices, Others) 5.2.4. By Company (2024) 5.2.5. By Region 5.3. Market Map 6. North America Veterinary CRO And CDMO Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Animal 6.2.2. By Service 6.2.3. By Application 6.2.4. By Country 6.3. North America: Country Analysis 6.3.1. United States Veterinary CRO And CDMO Market Outlook 6.3.1.1. Market Size & Forecast 6.3.1.1.1. By Value 6.3.1.2. Market Share & Forecast 6.3.1.2.1. By Animal 6.3.1.2.2. By Service 6.3.1.2.3. By Application 6.3.2. Mexico Veterinary CRO And CDMO Market Outlook 6.3.2.1. Market Size & Forecast 6.3.2.1.1. By Value 6.3.2.2. Market Share & Forecast 6.3.2.2.1. By Animal 6.3.2.2.2. By Service 6.3.2.2.3. By Application 6.3.3. Canada Veterinary CRO And CDMO Market Outlook 6.3.3.1. Market Size & Forecast 6.3.3.1.1. By Value 6.3.3.2. Market Share & Forecast 6.3.3.2.1. By Animal 6.3.3.2.2. By Service 6.3.3.2.3. By Application 7. Europe Veterinary CRO And CDMO Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Animal 7.2.2. By Service 7.2.3. By Application 7.2.4. By Country 7.3. Europe: Country Analysis 7.3.1. France Veterinary CRO And CDMO Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Animal 7.3.1.2.2. By Service 7.3.1.2.3. By Application 7.3.2. Germany Veterinary CRO And CDMO Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Animal 7.3.2.2.2. By Service 7.3.2.2.3. By Application 7.3.3. United Kingdom Veterinary CRO And CDMO Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Animal 7.3.3.2.2. By Service 7.3.3.2.3. By Application 7.3.4. Italy Veterinary CRO And CDMO Market Outlook 7.3.4.1. Market Size & Forecast 7.3.4.1.1. By Value 7.3.4.2. Market Share & Forecast 7.3.4.2.1. By Animal 7.3.4.2.2. By Service 7.3.4.2.3. By Application 7.3.5. Spain Veterinary CRO And CDMO Market Outlook 7.3.5.1. Market Size & Forecast 7.3.5.1.1. By Value 7.3.5.2. Market Share & Forecast 7.3.5.2.1. By Animal 7.3.5.2.2. By Service 7.3.5.2.3. By Application 8. Asia-Pacific Veterinary CRO And CDMO Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Animal 8.2.2. By Service 8.2.3. By Application 8.2.4. By Country 8.3. Asia-Pacific: Country Analysis 8.3.1. China Veterinary CRO And CDMO Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Animal 8.3.1.2.2. By Service 8.3.1.2.3. By Application 8.3.2. India Veterinary CRO And CDMO Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Animal 8.3.2.2.2. By Service 8.3.2.2.3. By Application 8.3.3. South Korea Veterinary CRO And CDMO Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Animal 8.3.3.2.2. By Service 8.3.3.2.3. By Application 8.3.4. Japan Veterinary CRO And CDMO Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Animal 8.3.4.2.2. By Service 8.3.4.2.3. By Application 8.3.5. Australia Veterinary CRO And CDMO Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Animal 8.3.5.2.2. By Service 8.3.5.2.3. By Application 9. South America Veterinary CRO And CDMO Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Animal 9.2.2. By Service 9.2.3. By Application 9.2.4. By Country 9.3. South America: Country Analysis 9.3.1. Brazil Veterinary CRO And CDMO Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Animal 9.3.1.2.2. By Service 9.3.1.2.3. By Application 9.3.2. Argentina Veterinary CRO And CDMO Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Animal 9.3.2.2.2. By Service 9.3.2.2.3. By Application 9.3.3. Colombia Veterinary CRO And CDMO Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Animal 9.3.3.2.2. By Service 9.3.3.2.3. By Application 10. Middle East and Africa Veterinary CRO And CDMO Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Animal 10.2.2. By Service 10.2.3. By Application 10.2.4. By Country 10.3. MEA: Country Analysis 10.3.1. South Africa Veterinary CRO And CDMO Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Animal 10.3.1.2.2. By Service 10.3.1.2.3. By Application 10.3.2. Saudi Arabia Veterinary CRO And CDMO Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Animal 10.3.2.2.2. By Service 10.3.2.2.3. By Application 10.3.3. UAE Veterinary CRO And CDMO Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Animal 10.3.3.2.2. By Service 10.3.3.2.3. By Application 11. Market Dynamics 11.1. Drivers 11.2. Challenges 12. Market Trends & Developments 12.1. Merger & Acquisition (If Any) 12.2. Product Launches (If Any) 12.3. Recent Developments 13. Disruptions: Conflicts, Pandemics and Trade Barriers 14. Porters Five Forces Analysis 14.1. Competition in the Industry 14.2. Potential of New Entrants 14.3. Power of Suppliers 14.4. Power of Customers 14.5. Threat of Substitute Products 15. Competitive Landscape 15.1. Fortrea Holdings Inc. 15.1.1. Business Overview 15.1.2. Company Snapshot 15.1.3. Products & Services 15.1.4. Financials (As Reported) 15.1.5. Recent Developments 15.1.6. Key Personnel Details 15.1.7. SWOT Analysis 15.2. Charles River Laboratories International, Inc. 15.3. Clinvet (Pty) Ltd. 15.4. KLIFOVET GmbH 15.5. Veterinary Research Management, Inc. 15.6. VETSPIN SRL 15.7. Inotiv, Inc. 15.8. IDEXX Laboratories, Inc. 15.9. Vetio Animal Health 15.10. TriRx Pharmaceutical Services, LLC 16. Strategic Recommendations 17. About Us & Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
TechSci Research社の ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD(veterinary)の最新刊レポート
よくあるご質問TechSci Research社はどのような調査会社ですか?テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|